You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Characterisation of the clinical phenotype in Phelan-McDermid syndrome
Contributor:
Burdeus-Olavarrieta, Mónica;
San José-Cáceres, Antonia;
García-Alcón, Alicia;
González-Peñas, Javier;
Hernández-Jusdado, Patricia;
Parellada-Redondo, Mara
Published:
Springer Science and Business Media LLC, 2021
Published in:
Journal of Neurodevelopmental Disorders, 13 (2021) 1
Language:
English
DOI:
10.1186/s11689-021-09370-5
ISSN:
1866-1947;
1866-1955
Origination:
Footnote:
Description:
Abstract Background Phelan-McDermid syndrome (PMS) is a rare genetic disorder compromising the 22q13 terminal region and affecting SHANK3, a gene crucial to the neurobehavioural phenotype and strongly linked to autism (ASD) and intellectual disability (ID). The condition is characterised by global developmental delay, ID, speech impairments, hypotonia and autistic behaviours, although its presentation and symptom severity vary widely. In this study, we provide a thorough description of the behavioural profile in PMS and explore differences related to deletion size and language ability. Methods We used standard clinical assessment instruments to measure altered behaviour, adaptive skills and autistic symptomatology in sixty participants with PMS (30 females, median age 8.5 years, SD=7.1). We recorded background information and other clinical manifestations and explored associations with deletion size. We performed descriptive and inferential analyses for group comparison. Results We found delayed gross and fine motor development, delayed and impaired language (~70% of participants non or minimally verbal), ID of different degrees and adaptive functioning ranging from severe to borderline impairment. Approximately 40% of participants experienced developmental regression, and half of those regained skills. Autistic symptoms were frequent and variable in severity, with a median ADOS-2 CSS score of 6 for every domain. Sensory processing anomalies, hyperactivity, attentional problems and medical comorbidities were commonplace. The degree of language and motor development appeared to be associated with deletion size. Conclusions This study adds to previous research on the clinical descriptions of PMS and supports results suggesting wide variability of symptom severity and its association with deletion size. It makes the case for suitable psychotherapeutic and pharmacological approaches, for longitudinal studies to strengthen our understanding of possible clinical courses and for more precise genomic analysis.